Intermittent therapy with 1,25 vitamin D and calcitonin prevents cyclosporin-induced alveolar bone loss in rats.

Calcified tissue international

Volumn 87, Issue 3, 2010, Pages 236-245

  Spolidorio, Luís C ^a   Herrera, Bruno S ^b   Coimbra, Leila S ^b   Spolidorio, Denise M P ^b   Muscará, Marcelo N ^b   Rossa Jr , C ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BONE DENSITY CONSERVATION AGENT; CALCITONIN; CALCITRIOL; CYCLOSPORIN; INTERLEUKIN DERIVATIVE; ISOENZYME; TARTRATE-RESISTANT ACID PHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BLOOD; CELL COUNT; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG ADMINISTRATION; JAW DISEASE; MALE; ORAL DRUG ADMINISTRATION; OSTEOCLAST; RAT; WISTAR RAT;

ACID PHOSPHATASE; ADMINISTRATION, ORAL; ALVEOLAR BONE LOSS; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; CALCITRIOL; CELL COUNT; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; INTERLEUKINS; ISOENZYMES; MALE; MANDIBULAR DISEASES; OSTEOCLASTS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85027947340     PISSN: None     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-010-9380-1     Document Type: Article

References (0)